First case of Gaisbock's syndrome reported in India: A report
Researchers have reported a case of Gaisbock's syndrome in an older man with hypertension that has been published in Journal of the Association of Physicians of India.
The patient's polycythemia cleared up after six weeks and returned to normal after a year. Gaisbock's syndrome, first reported in 1905, is a symptom complex associated with polycythemia that cannot be attributed to polycythemia rubra vera or a secondary erythrocytosis that has formed in reaction to hypoxemia. Male sex, hypertension, smoking, diuretic treatment, obesity, and mental or physical stress are all risk factors for the development of Gaisbock's syndrome.
A 73-year-old man was referred to the outpatient department of internal medicine at Manipal Hospital in Bangalore, the doctors discovered that he had a high RBC count, a high hemoglobin level, and a high hematocrit. Doctors performed physical examination of the patient's temperature, heart rate, blood pressure, respiratory rate and BMI, all were tested and came within normal performed a complete blood count which indicated increases in the patient's hematocrit (packed cell volume, PCV), hemoglobin, and red blood cell count. Other characteristics of red blood cells (mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration) were within normal ranges. They also found his vitamin B12 level to be low (96.6 pg/ml) and his blood uric acid level was found to be high (8.2 mg/dl). ABG revealed hypoxemia with pO2 (33.9 mmhg).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.